Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Wegovy

Influencer calls out advertisements for weight-loss drugs in New York City subway stations: ‘Dystopian’

‘Not only do we advertise prescription drugs in the US, we paper the stairs of the train with them,’ influencer says

The Independent UK

So, is Wegovy the same as Ozempic? Your need-to-knows about the controversial over-the-counter weight loss drugs

Two experts explain.

Marie Claire

Revealed: maker of Wegovy ‘skinny jab’ is funding NHS weight-loss services

Critics fear conflict of interest as Novo Nordisk helps medics ‘reduce unnecessary barriers’ to treatment for obesity

The Guardian - UK

From analysis to the latest developments in health,
read the most diverse news in one place.

‘Skinny jab’ drug firm facing fresh inquiries after ‘serious breaches’ of industry code

Pharmaceutical company behind blockbuster diet jab Wegovy confronts crises on multiple fronts, amid scrutiny of UK activities

The Guardian - UK

Firm behind Wegovy slimming jab suspended from UK trade association

Novo Nordisk found to be in breach of ABPI code of practice over sponsored weight-loss courses that promoted its medicines

The Guardian - UK

‘Orchestrated PR campaign’: how skinny jab drug firm sought to shape obesity debate

Maker of Wegovy, an appetite suppressor hailed as a weight-loss magic bullet, has spent millions on a slick PR campaign – including payments to some of its biggest cheerleaders

The Guardian - UK

What is Wegovy and who is eligible as NHS approves weight loss drug

A weight loss jab have been approved for use through the NHS for people with at least one weight-related condition and a BMI score of at least 35

Daily Mirror

Read news from The Economist, FT, and more,
with one subscription

Wegovy works. But here's what happens if you can't afford to keep taking the drug

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

WEKU

Semaglutide is causing a social media frenzy. So what is it?

It is not a a viral meme, but a drug that is an injectable medication — originally designed to treat diabetes — that has left those who need it waiting until next year for resupply.

ABC News

The growing market for weight loss drugs

A new generation of FDA-approved diabetes drugs that can also help patients lose weight has prompted enthusiasm from doctors and a firestorm of demand among patients so strong it's led to shortages.

Axios

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.